Concepedia

Author

Yoko Hirano

The University of TokyoORCID

Also Known As

Y Hirano, Y. Hirano, YOKO HIRANO, Yoko HIRANO, Yoko Hirano, Yui Hirano

41

Publications

445

Citations

11

H-Index

32

Concepts

All Affiliations

The University of TokyoNational Institute for Physiological SciencesNational Institutes of Natural SciencesPfizer (Japan)The Graduate University for Advanced Studies, SOKENDAI
YH

About

Yoko Hirano is an author at The University of Tokyo specializing in medicine, psychiatry, and psychopharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

77

2

Social Sciences

2

2

37

3

Engineering

1

1

23

4

Public Health

1

1

17

5

Biochemistry

1

1

23

Yoko Hirano

×

10

Publications

351

Citations

10

H-Index

YearCitations

LGI1–ADAM22–MAGUK configures transsynaptic nanoalignment for synaptic transmission and epilepsy prevention

Yuko Fukata, Xiumin Chen, Satomi Chiken,

Proceedings of the National Academy of Sciences

2021

102

Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2

Ryosuke Arakawa, Per Stenkrona, Akihiro Takano,

The International Journal of Neuropsychopharmacology

2019

65

Biallelic <i>ADAM22</i> pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy

Marieke M van der Knoop, Reza Maroofian, Yuko Fukata,

Brain

2022

41

Morphologic studies of sickle erythrocytes by image analysis.

Kazumi Horiuchi, J Ohata, Yoko Hirano,

PubMed

1990

39

Rapid assay for catechol-O-methyltransferase activity by high-performance liquid chromatography-fluorescence detection

Yoko Hirano, Makoto Tsunoda, Takashi Funatsu,

Journal of Chromatography B

2005

23

Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database

Yoko Hirano, Yoichi Ii

Clinical Drug Investigation

2019

23

Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.

Shûichi Ichikawa, Yoshihiro Tajima, Tetsuo Sakamaki,

Japanese Circulation Journal

1984

17

Suppression of Catechol-O-Methyltransferase Activity through Blunting of .ALPHA.2-Adrenoceptor Can Explain Hypertension in Dahl Salt-Sensitive Rats

Yoko Hirano, Makoto Tsunoda, Tatsuo Shimosawa,

Hypertension Research

2007

15

Risk of Extrapyramidal Syndromes Associated With Psychotropic Polypharmacy: A Study Based on Large-Scale Japanese Claims Data

Yoko Hirano

Therapeutic Innovation & Regulatory Science

2020

14

Systemic lupus erythematosus presenting with mixed‐type fulminant autoimmune hemolytic anemia

Yoko Hirano, Takaaki Itonaga, Hiroki Yasudo,

Pediatrics International

2016

12

Page 1